Literature DB >> 20238112

PET and PET/CT in gastrointestinal stromal tumours: the unanswered questions and the potential newer applications.

Sandip Basu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20238112     DOI： 10.1007/s00259-010-1404-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  26 in total

1.  Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate.

Authors:  B K P Goh; P K H Chow; K L Chuah; W M Yap; W K Wong
Journal:  Eur J Surg Oncol       Date:  2006-07-12       Impact factor: 4.424

2.  Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.

Authors:  T Heinicke; E Wardelmann; T Sauerbruch; H J Tschampa; A Glasmacher; H Palmedo
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

3.  Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor.

Authors:  Sebastian Bauer; Lynn K Yu; George D Demetri; Jonathan A Fletcher
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

4.  Metastasis in a benign duodenal stromal tumour.

Authors:  B Meesters; P A Pauwels; A M Pijnenburg; L T Vlasveld; O J Repelaer van Driel
Journal:  Eur J Surg Oncol       Date:  1998-08       Impact factor: 4.424

5.  The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.

Authors:  Isis Gayed; Thuan Vu; Revathy Iyer; Marcella Johnson; Homer Macapinlac; Nancy Swanston; Donald Podoloff
Journal:  J Nucl Med       Date:  2004-01       Impact factor: 10.057

6.  Heterogeneity of kinase inhibitor resistance mechanisms in GIST.

Authors:  B Liegl; I Kepten; C Le; M Zhu; G D Demetri; M C Heinrich; C D M Fletcher; C L Corless; J A Fletcher
Journal:  J Pathol       Date:  2008-09       Impact factor: 7.996

7.  Congestive heart failure during imatinib mesylate treatment.

Authors:  Gina Turrisi; Francesco Montagnani; Simone Grotti; Claudio Marinozzi; Leonardo Bolognese; Giammaria Fiorentini
Journal:  Int J Cardiol       Date:  2009-08-04       Impact factor: 4.164

Review 8.  Biology of gastrointestinal stromal tumors.

Authors:  Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

9.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

Review 10.  Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.

Authors:  Markku Miettinen; Mourad Majidi; Jerzy Lasota
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162
View more
  2 in total

Review 1.  Personalized versus evidence-based medicine with PET-based imaging.

Authors:  Sandip Basu
Journal:  Nat Rev Clin Oncol       Date:  2010-08-10       Impact factor: 66.675

2.  Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography.

Authors:  Sandip Basu; Nawab S Baghel
Journal:  Jpn J Radiol       Date:  2011-05-24       Impact factor: 2.374
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.